Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0IG5E
|
||||
| Former ID |
DNC009158
|
||||
| Drug Name |
2,5'-dichloro-5'-deoxy-N6-cyclopentyladenosine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530035] | ||
| Formula |
C15H19Cl2N5O3
|
||||
| Canonical SMILES |
C1CCC(C1)NC2=NC(=NC3=C2N=CN3C4C(C(C(O4)CCl)O)O)Cl
|
||||
| InChI |
1S/C15H19Cl2N5O3/c16-5-8-10(23)11(24)14(25-8)22-6-18-9-12(19-7-3-1-2-4-7)20-15(17)21-13(9)22/h6-8,10-11,14,23-24H,1-5H2,(H,19,20,21)/t8-,10-,11-,14-/m1/s1
|
||||
| InChIKey |
GWUOJELSUSGGDU-IDTAVKCVSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530035] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [530035] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [530035] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [530035] | ||
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.